SPHERA FUNDS MANAGEMENT LTD. - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$2,167,000
+183.3%
2,006,200
+33.7%
0.50%
+132.4%
Q4 2013$765,0001,500,0000.21%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$78,0000.04%
CONDOR CAPITAL MANAGEMENT 211,371$110,0000.03%
Benin Management CORP 83,000$43,0000.02%
First Heartland Consultants, Inc. 21,500$11,0000.01%
Advisory Services Network, LLC 23,000$12,0000.00%
Virtu KCG Holdings LLC 176,453$92,0000.00%
RELIANCE TRUST CO OF DELAWARE 50,000$26,0000.00%
TCI Wealth Advisors, Inc. 1,000$1,0000.00%
Renaissance Technologies 835,400$434,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders